EUROPE BONE GRAFT AND SUBSTITUTE MARKET FORECAST 2017-2025
KEY FINDINGS
The revenue generated by the Europe bone graft and substitute market is predicted to rise from $721 million in 2016 and reach $1055 million by the end of the forecast period of 2017-2025. The market is predicted to expand further at a CAGR of 4.48% over the said period.
MARKET INSIGHTS
The European market is classified on the basis of application, types and harvesting and fixation devices. The market is driven by rising health expenditure in countries such as the United Kingdom and France. This includes expenditures on health insurance being offered by government and private health insurance companies, which, in turn, is boosting the demand for the bone grafts and substitutes for surgeries such as joint reconstruction, bone implants, and hip replacements. Of all the European countries, the German market is expected to witness the highest CAGR growth. The country is the third largest medical technology market globally, after the United States and Japan.
COMPETITIVE INSIGHTS
Smith And Nephew Plc, Mathys European Orthopedic, Integra Lifesciences Corp, Medtronic Inc, XTANT Medical and Wright Medical Group N.V Holdings Inc, Baxter International Inc, Sigmagraft, Orthofix Holdings Inc, Zimmer Biomet Holdings Inc, Nuvasive Inc, Depuy Synthes Inc, and, Allosource Inc are some of the well-known players in this market.
The revenue generated by the Europe bone graft and substitute market is predicted to rise from $721 million in 2016 and reach $1055 million by the end of the forecast period of 2017-2025. The market is predicted to expand further at a CAGR of 4.48% over the said period.
MARKET INSIGHTS
The European market is classified on the basis of application, types and harvesting and fixation devices. The market is driven by rising health expenditure in countries such as the United Kingdom and France. This includes expenditures on health insurance being offered by government and private health insurance companies, which, in turn, is boosting the demand for the bone grafts and substitutes for surgeries such as joint reconstruction, bone implants, and hip replacements. Of all the European countries, the German market is expected to witness the highest CAGR growth. The country is the third largest medical technology market globally, after the United States and Japan.
COMPETITIVE INSIGHTS
Smith And Nephew Plc, Mathys European Orthopedic, Integra Lifesciences Corp, Medtronic Inc, XTANT Medical and Wright Medical Group N.V Holdings Inc, Baxter International Inc, Sigmagraft, Orthofix Holdings Inc, Zimmer Biomet Holdings Inc, Nuvasive Inc, Depuy Synthes Inc, and, Allosource Inc are some of the well-known players in this market.
1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. KEY FINDINGS
3.1.1. SPINAL FUSIONS TO LEAD THE APPLICATION SEGMENT
3.1.2. ALLOGRAFT DOMINATES THE EUROPE BONE GRAFT AND SUBSTITUTE MARKET
4. MARKET DETERMINANTS
4.1. DRIVERS
4.1.1. INCREASE IN TREATMENTS AND SURGERIES INVOLVING MUSCULOSKELETAL DISORDERS
4.1.2. AGING POPULATION IN KEY COUNTRIES
4.1.3. INCREASING SOPHISTICATION OF BIOCOMPATIBLE SYNTHETIC BONE GRAFTS
4.1.4. TECHNOLOGICAL ADVANCEMENTS
4.1.5. UNHEALTHY LIFESTYLE CHOICES LEADING TO A RISE IN DEGENERATIVE JOINT DISEASES
4.1.6. RISE IN SPINAL FUSION AND JOINT RECONSTRUCTION
4.1.7. INCREASE IN DEMAND FOR ORTHOPEDIC PROCEDURE
4.2. RESTRAINTS
4.2.1. INCREMENTAL RISE IN THE COST OF SURGERIES
4.2.2. ETHICAL ISSUES ASSOCIATED WITH BONE GRAFTING PROCEDURES
4.2.3. THE STRINGENT REGULATORY APPROVAL PROCESS
4.3. OPPORTUNITIES
4.3.1. RESEARCH AND INVESTMENT IN BIOENGINEERING LEADING TO THE DEVELOPMENT OF HYBRID MATERIAL FOR BONE GRAFTING
4.3.2. RISE IN REIMBURSEMENT FOR SURGERIES IN DEVELOPED NATIONS
4.4. CHALLENGES
4.4.1. SURGICAL RISK ASSOCIATED WITH REJECTION DUE TO IMMUNE RESPONSE
4.4.2. LIMITED SUPPLY AND HIGH DONOR SITE MORBIDITY RATE.FOR AUTOGRAPHS
4.4.3. INCREASED SCRUTINY OF STEM CELL-DERIVED PRODUCTS
4.4.4. OFF-LABEL USE OF BONE GRAFT MATERIAL
4.4.5. HIGH COST OF BONE GRAFTING SURGERIES
5. MARKET SEGMENTATION
5.1. MARKET BY TYPE 2017-2025
5.1.1. AUTOGRAFTS
5.1.2. ALLOGRAFT
5.1.3. SYNTHETICS AND ADDITIVES
5.2. MARKET BY APPLICATION 2017-2025
5.2.1. SPINAL FUSION
5.2.2. LONG BONE
5.2.3. FOOT AND ANKLE
5.2.4. CRANIOMAXILOFACIAL
5.2.5. JOINT RECONSTRUCTION
5.2.6. DENTAL BONE GRAFT
5.3. MARKET BY HARVESTING AND FIXATION DEVICES 2017-2025
5.3.1. SYNTHES RIA MARKET
5.3.2. IMPLANT HOLDER
5.3.3. PLATELET CONCENTRATE SYSTEM
5.3.4. TREPHINE ATTACHMENT TOOL
5.3.5. BONE MARROW ASPIRATE CONCENTRATED SYSTEM
5.3.6. OTHER HARVEST DEVICES
6. KEY ANALYTICS
6.1. PORTERS FIVE FORCES ANALYSIS
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTE PRODUCTS
6.1.3. BARGAINING POWER OF BUYER
6.1.4. BARGAINING POWER OF SUPPLIER
6.1.5. INTENSITY OF COMPETITIVE RIVALRY
6.2. KEY COMPANY ANALYSIS
6.3. KEY BUYING CRITERIA
7. GEOGRAPHIC ANALYSIS
7.1. EUROPE
7.1.1. THE UNITED KINGDOM
7.1.2. FRANCE
7.1.3. GERMANY
7.1.4. SPAIN
7.1.5. REST OF EUROPE
8. COMPANY PROFILE
8.1. COMPETITIVE ANALYSIS
8.1.1. MARKET SHARE ANALYSIS
8.1.2. REGIONAL INVESTMENT OPPORTUNITY
8.1.3. EMERGING OPPORTUNITIES
8.1.4. KEY STRATEGIES
8.2. ALLOSOURCE, INC.
8.2.1. OVERVIEW
8.2.2. PRODUCT PORTFOLIO
8.2.3. STRATEGIC INITIATIVES
8.2.4. SCOT ANALYSIS
8.3. BAXTER INTERNATIONAL INC.
8.3.1. OVERVIEW
8.3.2. PRODUCT PORTFOLIO
8.3.3. STRATEGIC INITIATIVES
8.3.4. SCOT ANALYSIS
8.4. DEPUY SYNTHES, INC
8.4.1. OVERVIEW
8.4.2. PRODUCT PORTFOLIO
8.4.3. STRATEGIC INITIATIVES
8.4.4. SCOT ANALYSIS
8.5. INTEGRA LIFESCIENCES CORP
8.5.1. OVERVIEW
8.5.2. PRODUCT PORTFOLIO
8.5.3. STRATEGIC INITIATIVES
8.5.4. SCOT ANALYSIS
8.6. MATHYS EUROPEAN ORTHOPEDIC
8.6.1. OVERVIEW
8.6.2. SCOT ANALYSIS
8.7. MEDTRONIC, INC.
8.7.1. OVERVIEW
8.7.2. PRODUCT PORTFOLIO
8.7.3. STRATEGIC INITIATIVES
8.7.4. SCOT ANALYSIS
8.8. NUVASIVE INC.
8.8.1. OVERVIEW
8.8.2. PRODUCT PORTFOLIO
8.8.3. STRATEGIC INITIATIVES
8.8.4. SCOT ANALYSIS
8.9. ORTHOFIX HOLDINGS, INC.
8.9.1. OVERVIEW
8.9.2. PRODUCT PORTFOLIO
8.9.3. STRATEGIC INITIATIVE
8.9.4. SCOT ANALYSIS
8.10. SIGMAGRAFT
8.10.1. OVERVIEW
8.10.2. PRODUCT PORTFOLIO
8.10.3. STRATEGIC INITIATIVE
8.10.4. SCOT ANALYSIS
8.11. SMITH AND NEPHEW PLC
8.11.1. OVERVIEW
8.11.2. PRODUCT PORTFOLIO
8.11.3. SCOT ANALYSIS
8.12. STRYKER CORPORATION
8.12.1. OVERVIEW
8.12.2. PRODUCT PORTFOLIO
8.12.3. STRATEGIC INITIATIVE
8.12.4. SCOT ANALYSIS
8.13. ZIMMER BIOMET HOLDINGS INC
8.13.1. OVERVIEW
8.13.2. PRODUCT PORTFOLIO
8.13.3. STRATEGIC INITIATIVES
8.13.4. SCOT ANALYSIS
8.14. WRIGHT MEDICAL GROUP N.V.
8.14.1. OVERVIEW
8.14.2. PRODUCT PORTFOLIO
8.14.3. STRATEGIC INITIATIVES
8.14.4. SCOT ANALYSIS
8.15. XTANT MEDICAL HOLDINGS, INC.
8.15.1. OVERVIEW
8.15.2. PRODUCT PORTFOLIO
8.15.3. STRATEGIC INITIATIVES
8.15.4. SCOT ANALYSIS
TABLE LIST
TABLE 1 EUROPE BONE GRAFTS AND SUBSTITUTE MARKET, 2017-2025 ($ MILLION)
TABLE 2 EUROPE BONE GRAFTS AND SUBSTITUTE MARKET BY TYPE 2017-2025 ($ MILLION)
TABLE 3 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN AUTOGRAFTS, 2017-2025 ($ MILLION)
TABLE 4 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN ALLOGRAFTS, 2017-2025 ($MILLION)
TABLE 5 EUROPE BONE GRAFTS SUBSTITUTE MARKET IN SYNTHETICS AND ADDITIVES MARKET 2017-2025 ($MILLION)
TABLE 6 EUROPE BONE GRAFTS AND SUBSTITUTE MARKET BY APPLICATION 2017-2025 ($ MILLION)
TABLE 7 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN SPINAL, 2017-2025 ($ MILLION)
TABLE 8 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN LONG BONE, 2017-2025 ($MILLION)
TABLE 9 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN FOOT AND ANKLE, 2017-2025 ($ MILLION)
TABLE 10 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN CRANOMAXILOFACIAL, 2017-2025 ($ MILLION)
TABLE 11 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN JOINT RECONSTRUCTION 2017-2025 ($ MILLION)
TABLE 12 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN DENTAL BONE GRAFT, 2017-2025 ($MILLION)
TABLE 13 EUROPE BONE GRAFTS AND SUBSTITUTE HARVESTING AND FIXATION DEVICES MARKET 2017-2025 ($ MILLION)
TABLE 14 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN SYNTHES RIA, 2017-2025 ($MILLION)
TABLE 15 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN IMPLANT HOLDER, 2017-2025 ($MILLION)
TABLE 16 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN PLATELET CONCENTRATE SYSTEM 2017-2025 ($MILLION)
TABLE 17 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN TREPHINE ATTACHMENT TOOL, 2017-2025 ($MILLION)
TABLE 18 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN BONE MARROW ASPIRATE CONCENTRATED SYSTEM, 2017-2025 ($MILLION)
TABLE 19 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN OTHER HARVESTING DEVICE, 2017-2025 ($MILLION)
TABLE 20 EUROPE BONE GRAFT AND SUBSTITUTE MARKET, 2017-2025 ($ MILLION)
FIGURE LIST
FIGURE 1 EUROPE BONE GRAFTS AND SUBSTITUTE MARKET 2017-2025 ($ MILLION)
FIGURE 2 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN SPINAL FUSION 2017-2025 ($ MILLION)
FIGURE 3 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN ALLOGRAFTS 2017-2025 ($ MILLION)
FIGURE 4 PERCENTAGE DISTRIBUTION OF POPULATION AGED ABOVE 65, 2015 & 2050
FIGURE 5 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN AUTOGRAFT 2017-2025 ($ MILLION)
FIGURE 6 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN ALLOGRAFTS 2017-2025 ($ MILLION)
FIGURE 7 EUROPE BONE GRAFTS SUBSTITUTE MARKET IN SYNTHETICS AND ADDITIVES 2017-2025 ($ MILLION)
FIGURE 8 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN SPINAL FUSION 2017-2025 ($ MILLION)
FIGURE 9 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN LONG BONE 2017-2025 ($ MILLION)
FIGURE 10 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN FOOT AND ANKLE 2017-2025 ($ MILLION)
FIGURE 11 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN CRANOMAXILOFACIAL 2017-2025 ($ MILLION)
FIGURE 12 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN JOINT RECONSTRUCTION 2017-2025 ($ MILLION)
FIGURE 13 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN DENTAL BONE GRAFT 2017-2025 ($ MILLION)
FIGURE 14 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN SYNTHES RIA 2017-2025 ($ MILLION)
FIGURE 15 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN IMPLANT HOLDER 2017-2025 ($ MILLION)
FIGURE 16 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN PLATELET CONCENTRATE SYSTEM 2017-2025 ($ MILLION)
FIGURE 17 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN TREPHINE ATTACHMENT TOOL MARKET 2017-2025 ($ MILLION)
FIGURE 18 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN BONE MARROW ASPIRATE CONCENTRATED SYSTEM 2017-2025 ($ MILLION)
FIGURE 19 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN OTHER HARVESTING DEVICE MARKET 2017-2025 ($ MILLION)
FIGURE 20 UNITED KINGDOM BONE GRAFT AND SUBSTITUTE MARKET 2017-2025 ($ MILLION)
FIGURE 21 FRANCE BONE GRAFT AND SUBSTITUTE MARKET 2017-2025 ($ MILLION)
FIGURE 22 GERMANY BONE GRAFT AND SUBSTITUTE MARKET 2017-2025 ($ MILLION)
FIGURE 23 SPAIN BONE GRAFT AND SUBSTITUTE MARKET 2017-2025 ($ MILLION)
FIGURE 24 REST OF EUROPE BONE GRAFT AND SUBSTITUTE MARKET 2017-2025 ($ MILLION)
FIGURE 25 BONE GRAFT & SUBSTITUTE MARKET SHARE OF MAJOR COMPANIES 2016
COMPANIES MENTIONED
2. ALLOSOURCE, INC.
3. BAXTER INTERNATIONAL INC.
4. DEPUY SYNTHES, INC
5. INTEGRA LIFESCIENCES CORP
6. MATHYS EUROPEAN ORTHOPEDIC
7. MEDTRONIC, INC.
8. NUVASIVE INC.
9. ORTHOFIX HOLDINGS, INC.
10. SIGMAGRAFT
11. SMITH AND NEPHEW PLC
12. STRYKER CORPORATION
13. ZIMMER BIOMET HOLDINGS INC
14. WRIGHT MEDICAL GROUP N.V.
15. XTANT MEDICAL HOLDINGS, INC.
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. KEY FINDINGS
3.1.1. SPINAL FUSIONS TO LEAD THE APPLICATION SEGMENT
3.1.2. ALLOGRAFT DOMINATES THE EUROPE BONE GRAFT AND SUBSTITUTE MARKET
4. MARKET DETERMINANTS
4.1. DRIVERS
4.1.1. INCREASE IN TREATMENTS AND SURGERIES INVOLVING MUSCULOSKELETAL DISORDERS
4.1.2. AGING POPULATION IN KEY COUNTRIES
4.1.3. INCREASING SOPHISTICATION OF BIOCOMPATIBLE SYNTHETIC BONE GRAFTS
4.1.4. TECHNOLOGICAL ADVANCEMENTS
4.1.5. UNHEALTHY LIFESTYLE CHOICES LEADING TO A RISE IN DEGENERATIVE JOINT DISEASES
4.1.6. RISE IN SPINAL FUSION AND JOINT RECONSTRUCTION
4.1.7. INCREASE IN DEMAND FOR ORTHOPEDIC PROCEDURE
4.2. RESTRAINTS
4.2.1. INCREMENTAL RISE IN THE COST OF SURGERIES
4.2.2. ETHICAL ISSUES ASSOCIATED WITH BONE GRAFTING PROCEDURES
4.2.3. THE STRINGENT REGULATORY APPROVAL PROCESS
4.3. OPPORTUNITIES
4.3.1. RESEARCH AND INVESTMENT IN BIOENGINEERING LEADING TO THE DEVELOPMENT OF HYBRID MATERIAL FOR BONE GRAFTING
4.3.2. RISE IN REIMBURSEMENT FOR SURGERIES IN DEVELOPED NATIONS
4.4. CHALLENGES
4.4.1. SURGICAL RISK ASSOCIATED WITH REJECTION DUE TO IMMUNE RESPONSE
4.4.2. LIMITED SUPPLY AND HIGH DONOR SITE MORBIDITY RATE.FOR AUTOGRAPHS
4.4.3. INCREASED SCRUTINY OF STEM CELL-DERIVED PRODUCTS
4.4.4. OFF-LABEL USE OF BONE GRAFT MATERIAL
4.4.5. HIGH COST OF BONE GRAFTING SURGERIES
5. MARKET SEGMENTATION
5.1. MARKET BY TYPE 2017-2025
5.1.1. AUTOGRAFTS
5.1.2. ALLOGRAFT
5.1.3. SYNTHETICS AND ADDITIVES
5.2. MARKET BY APPLICATION 2017-2025
5.2.1. SPINAL FUSION
5.2.2. LONG BONE
5.2.3. FOOT AND ANKLE
5.2.4. CRANIOMAXILOFACIAL
5.2.5. JOINT RECONSTRUCTION
5.2.6. DENTAL BONE GRAFT
5.3. MARKET BY HARVESTING AND FIXATION DEVICES 2017-2025
5.3.1. SYNTHES RIA MARKET
5.3.2. IMPLANT HOLDER
5.3.3. PLATELET CONCENTRATE SYSTEM
5.3.4. TREPHINE ATTACHMENT TOOL
5.3.5. BONE MARROW ASPIRATE CONCENTRATED SYSTEM
5.3.6. OTHER HARVEST DEVICES
6. KEY ANALYTICS
6.1. PORTERS FIVE FORCES ANALYSIS
6.1.1. THREAT OF NEW ENTRANTS
6.1.2. THREAT OF SUBSTITUTE PRODUCTS
6.1.3. BARGAINING POWER OF BUYER
6.1.4. BARGAINING POWER OF SUPPLIER
6.1.5. INTENSITY OF COMPETITIVE RIVALRY
6.2. KEY COMPANY ANALYSIS
6.3. KEY BUYING CRITERIA
7. GEOGRAPHIC ANALYSIS
7.1. EUROPE
7.1.1. THE UNITED KINGDOM
7.1.2. FRANCE
7.1.3. GERMANY
7.1.4. SPAIN
7.1.5. REST OF EUROPE
8. COMPANY PROFILE
8.1. COMPETITIVE ANALYSIS
8.1.1. MARKET SHARE ANALYSIS
8.1.2. REGIONAL INVESTMENT OPPORTUNITY
8.1.3. EMERGING OPPORTUNITIES
8.1.4. KEY STRATEGIES
8.2. ALLOSOURCE, INC.
8.2.1. OVERVIEW
8.2.2. PRODUCT PORTFOLIO
8.2.3. STRATEGIC INITIATIVES
8.2.4. SCOT ANALYSIS
8.3. BAXTER INTERNATIONAL INC.
8.3.1. OVERVIEW
8.3.2. PRODUCT PORTFOLIO
8.3.3. STRATEGIC INITIATIVES
8.3.4. SCOT ANALYSIS
8.4. DEPUY SYNTHES, INC
8.4.1. OVERVIEW
8.4.2. PRODUCT PORTFOLIO
8.4.3. STRATEGIC INITIATIVES
8.4.4. SCOT ANALYSIS
8.5. INTEGRA LIFESCIENCES CORP
8.5.1. OVERVIEW
8.5.2. PRODUCT PORTFOLIO
8.5.3. STRATEGIC INITIATIVES
8.5.4. SCOT ANALYSIS
8.6. MATHYS EUROPEAN ORTHOPEDIC
8.6.1. OVERVIEW
8.6.2. SCOT ANALYSIS
8.7. MEDTRONIC, INC.
8.7.1. OVERVIEW
8.7.2. PRODUCT PORTFOLIO
8.7.3. STRATEGIC INITIATIVES
8.7.4. SCOT ANALYSIS
8.8. NUVASIVE INC.
8.8.1. OVERVIEW
8.8.2. PRODUCT PORTFOLIO
8.8.3. STRATEGIC INITIATIVES
8.8.4. SCOT ANALYSIS
8.9. ORTHOFIX HOLDINGS, INC.
8.9.1. OVERVIEW
8.9.2. PRODUCT PORTFOLIO
8.9.3. STRATEGIC INITIATIVE
8.9.4. SCOT ANALYSIS
8.10. SIGMAGRAFT
8.10.1. OVERVIEW
8.10.2. PRODUCT PORTFOLIO
8.10.3. STRATEGIC INITIATIVE
8.10.4. SCOT ANALYSIS
8.11. SMITH AND NEPHEW PLC
8.11.1. OVERVIEW
8.11.2. PRODUCT PORTFOLIO
8.11.3. SCOT ANALYSIS
8.12. STRYKER CORPORATION
8.12.1. OVERVIEW
8.12.2. PRODUCT PORTFOLIO
8.12.3. STRATEGIC INITIATIVE
8.12.4. SCOT ANALYSIS
8.13. ZIMMER BIOMET HOLDINGS INC
8.13.1. OVERVIEW
8.13.2. PRODUCT PORTFOLIO
8.13.3. STRATEGIC INITIATIVES
8.13.4. SCOT ANALYSIS
8.14. WRIGHT MEDICAL GROUP N.V.
8.14.1. OVERVIEW
8.14.2. PRODUCT PORTFOLIO
8.14.3. STRATEGIC INITIATIVES
8.14.4. SCOT ANALYSIS
8.15. XTANT MEDICAL HOLDINGS, INC.
8.15.1. OVERVIEW
8.15.2. PRODUCT PORTFOLIO
8.15.3. STRATEGIC INITIATIVES
8.15.4. SCOT ANALYSIS
TABLE LIST
TABLE 1 EUROPE BONE GRAFTS AND SUBSTITUTE MARKET, 2017-2025 ($ MILLION)
TABLE 2 EUROPE BONE GRAFTS AND SUBSTITUTE MARKET BY TYPE 2017-2025 ($ MILLION)
TABLE 3 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN AUTOGRAFTS, 2017-2025 ($ MILLION)
TABLE 4 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN ALLOGRAFTS, 2017-2025 ($MILLION)
TABLE 5 EUROPE BONE GRAFTS SUBSTITUTE MARKET IN SYNTHETICS AND ADDITIVES MARKET 2017-2025 ($MILLION)
TABLE 6 EUROPE BONE GRAFTS AND SUBSTITUTE MARKET BY APPLICATION 2017-2025 ($ MILLION)
TABLE 7 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN SPINAL, 2017-2025 ($ MILLION)
TABLE 8 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN LONG BONE, 2017-2025 ($MILLION)
TABLE 9 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN FOOT AND ANKLE, 2017-2025 ($ MILLION)
TABLE 10 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN CRANOMAXILOFACIAL, 2017-2025 ($ MILLION)
TABLE 11 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN JOINT RECONSTRUCTION 2017-2025 ($ MILLION)
TABLE 12 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN DENTAL BONE GRAFT, 2017-2025 ($MILLION)
TABLE 13 EUROPE BONE GRAFTS AND SUBSTITUTE HARVESTING AND FIXATION DEVICES MARKET 2017-2025 ($ MILLION)
TABLE 14 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN SYNTHES RIA, 2017-2025 ($MILLION)
TABLE 15 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN IMPLANT HOLDER, 2017-2025 ($MILLION)
TABLE 16 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN PLATELET CONCENTRATE SYSTEM 2017-2025 ($MILLION)
TABLE 17 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN TREPHINE ATTACHMENT TOOL, 2017-2025 ($MILLION)
TABLE 18 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN BONE MARROW ASPIRATE CONCENTRATED SYSTEM, 2017-2025 ($MILLION)
TABLE 19 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN OTHER HARVESTING DEVICE, 2017-2025 ($MILLION)
TABLE 20 EUROPE BONE GRAFT AND SUBSTITUTE MARKET, 2017-2025 ($ MILLION)
FIGURE LIST
FIGURE 1 EUROPE BONE GRAFTS AND SUBSTITUTE MARKET 2017-2025 ($ MILLION)
FIGURE 2 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN SPINAL FUSION 2017-2025 ($ MILLION)
FIGURE 3 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN ALLOGRAFTS 2017-2025 ($ MILLION)
FIGURE 4 PERCENTAGE DISTRIBUTION OF POPULATION AGED ABOVE 65, 2015 & 2050
FIGURE 5 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN AUTOGRAFT 2017-2025 ($ MILLION)
FIGURE 6 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN ALLOGRAFTS 2017-2025 ($ MILLION)
FIGURE 7 EUROPE BONE GRAFTS SUBSTITUTE MARKET IN SYNTHETICS AND ADDITIVES 2017-2025 ($ MILLION)
FIGURE 8 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN SPINAL FUSION 2017-2025 ($ MILLION)
FIGURE 9 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN LONG BONE 2017-2025 ($ MILLION)
FIGURE 10 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN FOOT AND ANKLE 2017-2025 ($ MILLION)
FIGURE 11 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN CRANOMAXILOFACIAL 2017-2025 ($ MILLION)
FIGURE 12 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN JOINT RECONSTRUCTION 2017-2025 ($ MILLION)
FIGURE 13 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN DENTAL BONE GRAFT 2017-2025 ($ MILLION)
FIGURE 14 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN SYNTHES RIA 2017-2025 ($ MILLION)
FIGURE 15 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN IMPLANT HOLDER 2017-2025 ($ MILLION)
FIGURE 16 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN PLATELET CONCENTRATE SYSTEM 2017-2025 ($ MILLION)
FIGURE 17 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN TREPHINE ATTACHMENT TOOL MARKET 2017-2025 ($ MILLION)
FIGURE 18 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN BONE MARROW ASPIRATE CONCENTRATED SYSTEM 2017-2025 ($ MILLION)
FIGURE 19 EUROPE BONE GRAFT AND SUBSTITUTE MARKET IN OTHER HARVESTING DEVICE MARKET 2017-2025 ($ MILLION)
FIGURE 20 UNITED KINGDOM BONE GRAFT AND SUBSTITUTE MARKET 2017-2025 ($ MILLION)
FIGURE 21 FRANCE BONE GRAFT AND SUBSTITUTE MARKET 2017-2025 ($ MILLION)
FIGURE 22 GERMANY BONE GRAFT AND SUBSTITUTE MARKET 2017-2025 ($ MILLION)
FIGURE 23 SPAIN BONE GRAFT AND SUBSTITUTE MARKET 2017-2025 ($ MILLION)
FIGURE 24 REST OF EUROPE BONE GRAFT AND SUBSTITUTE MARKET 2017-2025 ($ MILLION)
FIGURE 25 BONE GRAFT & SUBSTITUTE MARKET SHARE OF MAJOR COMPANIES 2016
COMPANIES MENTIONED
2. ALLOSOURCE, INC.
3. BAXTER INTERNATIONAL INC.
4. DEPUY SYNTHES, INC
5. INTEGRA LIFESCIENCES CORP
6. MATHYS EUROPEAN ORTHOPEDIC
7. MEDTRONIC, INC.
8. NUVASIVE INC.
9. ORTHOFIX HOLDINGS, INC.
10. SIGMAGRAFT
11. SMITH AND NEPHEW PLC
12. STRYKER CORPORATION
13. ZIMMER BIOMET HOLDINGS INC
14. WRIGHT MEDICAL GROUP N.V.
15. XTANT MEDICAL HOLDINGS, INC.
